TABLE 3.
Treatment and relapses in patients with Whipple's disease
| Antibioticsb | No. of relapsesa
|
Total no. (%) | ||||
|---|---|---|---|---|---|---|
| Ref. 95 | Ref. 64 | Ref. 10 | Ref. 75 | Ref. 50 | ||
| TCN | 21/49 | 2/14 | 2/12 | 4/8 | 5/28 | 34/111 (30) |
| TCN + Other | 2/15 | 0/8 | 0/2 | 1/4 | 0/0 | 3/29 (10) |
| PCN | 3/8 | 0/2 | 0/0 | 0/0 | 0/0 | 3/10 (30) |
| PCN + STM | 2/5 | 0/1 | 0/0 | 0/0 | 0/0 | 2/6 (33) |
| TMP-SMX | 0/3 | 0/0 | 0/0 | 0/6 | 0/12 | 0/21 (0) |
| Other | 3/8 | 0/0 | 1/5 | 0/0 | 2/12 | 6/25 (24) |
| Total | 31/88 | 2/25 | 3/19 | 5/18 | 7/52 | 48/202 (24) |
a
Number of relapses per number of treated patients.
b
TCN, tetracycline; PCN, penicillin; STM, streptomycin; TMP-SMX, trimethoprim-sulfamethoxazole.